Recent NM-INBRE News

National Institute of General Medical Sciences debuts Pathways

 

The National Institute of General Medical Sciences is excited to debut Pathways, from NIGMS and Scholastic, Inc. Pathways is a collection of free materials that teaches students about basic science and career pathways. Check out these resources, including a student magazine featuring researchers funded by NIGMS: Pathways.


New Mexico INBRE investigator Dr. Kevin Houston has been awarded $1 million by the NIH

New Mexico INBRE investigator Dr. Kevin Houston has been awarded a $1 million, four-year grant from the National Institutes of Health (NIH) to investigate how GPER1-dependent mechanisms of tamoxifen action contribute to tamoxifen resistance in breast cancer cells. 

The goal of this multiyear study entitled “GPER1-Dependent Regulation of IGF-1R in Tamoxifen Treated Breast Cancer Cells” is to further characterize how GPER1 is involved in the development of tamoxifen resistance in breast cancer cells and to identify potential targets for future design of pharmaceutical treatments that can lessen the likelihood that resistance will develop in breast cancer patients that are treated with tamoxifen.

In addition, this funding will provide the resources necessary to encourage and support both undergraduate and graduate students in research training while they are completing their studies at NMSU. 


Drug discovered by New Mexico INBRE’s UNM Liaison Dr. Eric Prossnitz and former NM-INBRE Director Dr. Jeff Arterburn could lead to new cancer treatments

Fifteen years after a chance meeting started their partnership, a compound Jeffrey Arterburn, and Eric Prossnitz discovered may lead to new skin cancer treatments.

Arterburn, a Regents professor in chemistry and biochemistry at New Mexico State University, and Prossnitz, a professor in the Department of Internal Medicine at The University of New Mexico Comprehensive Cancer Center, met after a regional scientific conference in 2003. Arterburn told Prossnitz about some compounds he had developed that might help Prossnitz’s research. The two quickly realized that their work dovetailed nicely. Complete Article


CONGRATULATIONS TO OUR NM-INBRE INVESTIGATOR RODOLFO TELLO-ABURTO

Congratulations to Dr. Rodolfo Tello-Aburto, one of our INBRE investigators for recently receiving federal funding by NIH for his R15 entitled “Structure-Activity Relationship Studies of Peptide Beta-Lactones as Proteasome Inhibitors and Anticancer Agents“.